Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
4.42 USD +5.24% Intraday chart for Lantern Pharma Inc. +0.91% +3.27%
Jul. 10 Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for Use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184 CI
Jul. 01 Lantern Pharma Inc.(NasdaqCM:LTRN) dropped from Russell Microcap Value Index CI

Evolution of the average Target Price on Lantern Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

f3012c01dd5815049e6c6bd3895591.fZvdsqTzkFHHYSEaUqszE565wqzbSRy4_gXvWGxiMkU.JdSsi-e09GK2UhF5KM9-ea_Bqv7qL3nRyDaAMw0QdB1L3LrU0JDxM7cIeA~1e78bbe3f9ab8ba0df6f917641abab9c

Analyst Recommendations on Lantern Pharma Inc.

HC Wainwright Starts Lantern Pharma at Neutral MT
EF Hutton Starts Lantern Pharma at Buy With $11 Price Target MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $36 From $34, Reiterates Buy Rating MT
HC Wainwright Adjusts Lantern Pharma's Price Target to $34 From $32, Keeps Buy Rating MT
LANTERN PHARMA : HC Wainwright Starts Lantern Pharma at Buy with $32 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.42 USD
Average target price
22 USD
Spread / Average Target
+397.74%
High Price Target
26 USD
Spread / Highest target
+488.24%
Low Price Target
18 USD
Spread / Lowest Target
+307.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lantern Pharma Inc.

HC Wainwright
EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. Consensus Lantern Pharma Inc.